PTPRC and neoplasm: Results demonstrated a significant increase in the infiltration of CD45+ immune cells in tumor tissues treated with VNP@Sgc8c-MMAE compared to control groups (Fig. 8b), indicating a robust immune response facilitated by the bacterial carrier.